Bryan D. Anderson

2.0k total citations
18 papers, 1.0k citations indexed

About

Bryan D. Anderson is a scholar working on Molecular Biology, Oncology and Renewable Energy, Sustainability and the Environment. According to data from OpenAlex, Bryan D. Anderson has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Renewable Energy, Sustainability and the Environment. Recurrent topics in Bryan D. Anderson's work include TGF-β signaling in diseases (5 papers), Electrocatalysts for Energy Conversion (3 papers) and Nanomaterials for catalytic reactions (3 papers). Bryan D. Anderson is often cited by papers focused on TGF-β signaling in diseases (5 papers), Electrocatalysts for Energy Conversion (3 papers) and Nanomaterials for catalytic reactions (3 papers). Bryan D. Anderson collaborates with scholars based in United States, China and Spain. Bryan D. Anderson's co-authors include Joseph B. Tracy, Robert M. Campbell, Jonathan M. Yingling, Lei Yan, Faming Zhang, William T. McMillen, J. Scott Sawyer, Edward C. Smith, Douglas W. Beight and David K. Herron and has published in prestigious journals such as Chemistry of Materials, Cancer Research and ACS Applied Materials & Interfaces.

In The Last Decade

Bryan D. Anderson

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan D. Anderson United States 12 420 263 214 206 183 18 1.0k
Tianshu Li United States 18 191 0.5× 469 1.8× 480 2.2× 249 1.2× 268 1.5× 27 1.5k
Michael Förster Germany 15 233 0.6× 185 0.7× 178 0.8× 125 0.6× 179 1.0× 28 708
Tong Mou China 22 266 0.6× 459 1.7× 124 0.6× 49 0.2× 274 1.5× 60 1.4k
Xiaojie Jiang China 14 181 0.4× 189 0.7× 110 0.5× 79 0.4× 160 0.9× 40 652
Xi Xu China 22 503 1.2× 337 1.3× 144 0.7× 183 0.9× 301 1.6× 63 1.3k
Yasutaka Sasaki Japan 16 557 1.3× 345 1.3× 43 0.2× 201 1.0× 238 1.3× 46 1.4k
Dongcheng Liu China 19 184 0.4× 505 1.9× 107 0.5× 187 0.9× 124 0.7× 87 1.2k
Ye Qu China 17 228 0.5× 208 0.8× 79 0.4× 218 1.1× 81 0.4× 42 1.1k

Countries citing papers authored by Bryan D. Anderson

Since Specialization
Citations

This map shows the geographic impact of Bryan D. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan D. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan D. Anderson more than expected).

Fields of papers citing papers by Bryan D. Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan D. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan D. Anderson. The network helps show where Bryan D. Anderson may publish in the future.

Co-authorship network of co-authors of Bryan D. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan D. Anderson. A scholar is included among the top collaborators of Bryan D. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan D. Anderson. Bryan D. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gong, Xueqian, Hong Gao, Mark H. Bender, et al.. (2024). Abstract 3316: LY3962673, an oral, highly potent, mutant-selective, and non-covalent KRAS G12D inhibitor demonstrates robust anti-tumor activity in KRAS G12D models. Cancer Research. 84(6_Supplement). 3316–3316. 7 indexed citations
2.
Li, Binghui, Trent R. Stewart, Tao Wang, et al.. (2023). Abstract B115: Preclinical characterization of LY3962673, an orally bioavailable, highly potent, and selective KRAS G12D inhibitor. Molecular Cancer Therapeutics. 22(12_Supplement). B115–B115.
3.
Anderson, Bryan D., et al.. (2020). Sulfidation and selenidation of nickel nanoparticles. Carbon Energy. 3(4). 582–589. 21 indexed citations
4.
Kennedy, W. Joshua, et al.. (2018). Thermal Reshaping Dynamics of Gold Nanorods: Influence of Size, Shape, and Local Environment. ACS Applied Materials & Interfaces. 10(50). 43865–43873. 27 indexed citations
5.
Anderson, Bryan D., et al.. (2017). Synthesis and chemical transformation of Ni nanoparticles embedded in silica. Nanoscale. 9(47). 18959–18965. 7 indexed citations
6.
Johnston‐Peck, Aaron C., et al.. (2017). Size and Composition Control of CoNi Nanoparticles and Their Conversion into Phosphides. Chemistry of Materials. 29(7). 2739–2747. 21 indexed citations
7.
Anderson, Bryan D., Wei‐Chen Wu, & Joseph B. Tracy. (2016). Silica Overcoating of CdSe/CdS Core/Shell Quantum Dot Nanorods with Controlled Morphologies. Chemistry of Materials. 28(14). 4945–4952. 36 indexed citations
8.
Anderson, Bryan D. & Joseph B. Tracy. (2014). Nanoparticle conversion chemistry: Kirkendall effect, galvanic exchange, and anion exchange. Nanoscale. 6(21). 12195–12216. 306 indexed citations
9.
Saraç, Mehmet Fahri, Bryan D. Anderson, Justin G. Railsback, et al.. (2013). Airbrushed Nickel Nanoparticles for Large-Area Growth of Vertically Aligned Carbon Nanofibers on Metal (Al, Cu, Ti) Surfaces. ACS Applied Materials & Interfaces. 5(18). 8955–8960. 4 indexed citations
10.
Railsback, Justin G., Bryan D. Anderson, Mehmet Fahri Saraç, et al.. (2013). Transfer of Vertically Aligned Carbon Nanofibers to Polydimethylsiloxane (PDMS) While Maintaining their Alignment and Impalefection Functionality. ACS Applied Materials & Interfaces. 5(3). 878–882. 6 indexed citations
11.
12.
13.
Hamdouchi, Chafiq, Boyu Zhong, J. S. MENDOZA, et al.. (2005). Structure-based design of a new class of highly selective aminoimidazo[1,2-a]pyridine-based inhibitors of cyclin dependent kinases. Bioorganic & Medicinal Chemistry Letters. 15(7). 1943–1947. 78 indexed citations
14.
Sawyer, J. Scott, Douglas W. Beight, Bryan D. Anderson, et al.. (2004). Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-β type I receptor kinase domain. Bioorganic & Medicinal Chemistry Letters. 14(13). 3581–3584. 141 indexed citations
15.
Li, Hongyu, Yan Wang, Lei Yan, et al.. (2004). Novel and potent transforming growth factor beta type I receptor kinase domain inhibitor: 7-amino 4-(2-pyridin-2-yl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)-quinolines. Bioorganic & Medicinal Chemistry Letters. 14(13). 3585–3588. 22 indexed citations
16.
17.
Sawyer, J. Scott, Bryan D. Anderson, Douglas W. Beight, et al.. (2003). Synthesis and Activity of New Aryl- and Heteroaryl-Substituted Pyrazole Inhibitors of the Transforming Growth Factor-β Type I Receptor Kinase Domain. Journal of Medicinal Chemistry. 46(19). 3953–3956. 197 indexed citations
18.
Zhu, Guoxin, Scott E. Conner, Xun Zhou, et al.. (2003). Synthesis, Structure−Activity Relationship, and Biological Studies of Indolocarbazoles as Potent Cyclin D1-CDK4 Inhibitors. Journal of Medicinal Chemistry. 46(11). 2027–2030. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tianshu Li Breakdown of academic impact, for papers by Michael Förster Breakdown of academic impact, for papers by Tong Mou Breakdown of academic impact, for papers by Xiaojie Jiang Breakdown of academic impact, for papers by Xi Xu Breakdown of academic impact, for papers by Yasutaka Sasaki Breakdown of academic impact, for papers by Dongcheng Liu Breakdown of academic impact, for papers by Ye Qu
Rankless by CCL
2026